Cardiovascular Essentials for Advanced Practice Providers Revamp-Hypertension and Hyperlipidemia Video

Video Transcription

Video Summary

This module reviewed the management of hypertension and hyperlipidemia, two very common cardiovascular risk factors. For hypertension, it covered BP categories, ASCVD risk assessment, white coat hypertension, and the importance of detecting end-organ damage. It emphasized modifiable risks such as obesity, high sodium intake, smoking, alcohol, inactivity, and sleep apnea, plus secondary causes like renal disease, endocrine disorders, and medications. Treatment focuses on lifestyle changes and first-line agents such as thiazides, ACE inhibitors, ARBs, and calcium channel blockers, with urgent or emergency cases requiring careful blood pressure reduction and ICU-level care if end-organ damage is present. For hyperlipidemia, the lecture explained risk from abnormal lipoprotein particles, familial hypercholesterolemia, and when to start statins based on ASCVD risk or existing disease. It also reviewed ezetimibe, PCSK9 inhibitors, fibrates, and omega-3s, along with monitoring and LDL goals.

Keywords

hypertension

hyperlipidemia

ASCVD risk

statins

blood pressure management

LDL goals